BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 31816074)

  • 1. Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria.
    Orubu ESF; Robert FO; Samuel M; Megbule D
    Health Policy Plan; 2019 Dec; 34(Supplement_3):iii20-iii26. PubMed ID: 31816074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.
    Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD
    BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
    Osuafor NG; Ukwe CV; Okonta M
    PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
    Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
    Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
    Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
    J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
    PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Availability, prices and affordability of selected essential medicines in Jordan: a national survey.
    Alefan Q; Amairi R; Tawalbeh S
    BMC Health Serv Res; 2018 Oct; 18(1):787. PubMed ID: 30340486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
    Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R
    Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.
    Moye-Holz D; Ewen M; Dreser A; Bautista-Arredondo S; Soria-Saucedo R; van Dijk JP; Reijneveld SA; Hogerzeil HV
    BMC Health Serv Res; 2020 May; 20(1):424. PubMed ID: 32410676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria.
    Ozoh OB; Eze JN; Garba BI; Ojo OO; Okorie EM; Yiltok E; Okoli CV; Hammangabdo A; Beran D
    Trop Med Int Health; 2021 Jan; 26(1):54-65. PubMed ID: 32985028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China.
    Yang C; Hu S; Zhu Y; Zhu W; Li Z; Fang Y
    PLoS One; 2019; 14(10):e0223769. PubMed ID: 31618273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prices, availability and affordability of medicines in Rwanda.
    Bizimana T; Kayumba PC; Heide L
    PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
    Ewen M; Zweekhorst M; Regeer B; Laing R
    PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
    Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
    BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all.
    Kotwani A
    BMC Health Serv Res; 2013 Jul; 13():285. PubMed ID: 23885985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia.
    Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J
    PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.
    Sado E; Sufa A
    BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana.
    Mensah KB; Mensah ABB; Bangalee V; Padayachee N; Oosthuizen F
    BMC Cancer; 2021 Jun; 21(1):683. PubMed ID: 34112117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka.
    Dabare PR; Wanigatunge CA; Beneragama BH
    BMC Public Health; 2014 Aug; 14():817. PubMed ID: 25103467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability, prices and affordability of essential medicines in Zhejiang Province, China.
    Dong Z; Tao Q; Yan B; Sun G
    PLoS One; 2020; 15(11):e0241761. PubMed ID: 33232336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.